申请人:[en]THE GENERAL HOSPITAL CORPORATION
公开号:WO2022261627A1
公开(公告)日:2022-12-15
The present application provides a compound of Formula (I) as described herein, or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions comprising the compound of Formula (I), and methods of using said compound and said compositions for treating neurodegenerative diseases, are also provided.